Ticker Details
Dyne Therapeutics, Inc.
IPO Date:	September 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.19B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.24%
Avg Daily Range (30 D):	$0.62 | 3.58%
Avg Daily Range (90 D):	$0.54 | 3.00%

Institutional Daily Volume
Avg Daily Volume:	.87M
Avg Daily Volume (30 D):	1.9M
Avg Daily Volume (90 D):	1.95M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	77

Institutional Trades
Total Institutional Trades:	2,433
Avg Institutional Trade:	$2.52M
Avg Institutional Trade (30 D):	$2.41M
Avg Institutional Trade (90 D):	$2.53M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.37M
Avg Closing Trade (30 D):	$5.93M
Avg Closing Trade (90 D):	$6.2M
Avg Closing Volume:	234.24K

News

Mar 8, 2026 @ 10:01 PM Dyne Therapeutics Announces Initiation of Phase 3 ... Source: Na

Feb 22, 2026 @ 9:00 PM Dyne Therapeutics Announces Upcoming Presentations... Source: Na

Dec 10, 2025 @ 2:42 AM Dyne Therapeutics Announces Pricing of Upsized $35... Source: Dyne Therapeutics

Dec 9, 2025 @ 9:34 PM Biggest Market Movers Today, Dec. 9: WRBY, DYN, & ... Source: Dan Caplinger

Oct 27, 2025 @ 10:17 PM Why Dyne Therapeutics Stock Crushed the Market on ... Source: Eric Volkman

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.47	$-.73	$-3.47
Diluted EPS	$-3.47	$-.73	$-3.47
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-446.21M	$-111.96M	$-446.21M
Operating Income / Loss	$-468.18M	$-116.13M	$-468.18M
Cost of Revenue
Net Cash Flow	$458.35M	$320.12M	$458.35M
PE Ratio